Progress in diagnosis and treatment of primary prostatic signet ring cell carcinoma
10.3760/cma.j.cn112330-20230825-00055
- VernacularTitle:原发性前列腺印戒细胞癌的诊疗进展
- Author:
Hao WANG
1
;
Dawei XIE
;
Siqi WANG
;
Xin LI
;
Pushen YANG
;
Weifeng HE
;
Jianwen WANG
Author Information
1. 首都医科大学附属北京朝阳医院泌尿外科，北京 100020
- Keywords:
Prostatic neoplasms;
Carcinoma;
Signet ring cell
- From:
Chinese Journal of Urology
2024;45(8):641-644
- CountryChina
- Language:Chinese
-
Abstract:
Primary prostate signet ring cell carcinoma (PPSRCC) is one of the extremely rare malignant tumors in the male urogenital system, and its diagnosis mainly relies on pathological and immunohistochemical examination. Compared with typical prostate cancer, PPSRCC is characterized by more aggressive with less treatment response and poor prognosis. Current researches on the pathogenesis, clinical manifestations, pathological characteristics, diagnosis, treatment and prognosis of PPSRCC were reviewed.
